(MedPage Today) — AstraZeneca on Friday became the second major pharmaceutical manufacturer to announce it had agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration that avoided its threats…
Source link : https://www.medpagetoday.com/publichealthpolicy/medicaid/117912
Author :
Publish date : 2025-10-13 15:16:00
Copyright for syndicated content belongs to the linked Source.
